149 related articles for article (PubMed ID: 31736873)
1. Resveratrol Reverses Retinoic Acid Resistance of Anaplastic Thyroid Cancer Cells via Demethylating CRABP2 Gene.
Liu X; Li H; Wu ML; Wu J; Sun Y; Zhang KL; Liu J
Front Endocrinol (Lausanne); 2019; 10():734. PubMed ID: 31736873
[No Abstract] [Full Text] [Related]
2. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.
Li YT; Tian XT; Wu ML; Zheng X; Kong QY; Cheng XX; Zhu GW; Liu J; Li H
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596381
[TBL] [Abstract][Full Text] [Related]
3. Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations.
Lu MD; Li H; Nie JH; Li S; Ye HS; Li TT; Wu ML; Liu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430869
[TBL] [Abstract][Full Text] [Related]
4. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells.
Zheng X; Jia B; Tian XT; Song X; Wu ML; Kong QY; Li H; Liu J
Oxid Med Cell Longev; 2018; 2018():6235417. PubMed ID: 30116486
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation status of CRABP2 promoter down-regulates its expression.
Zhang GM; Song CC; Li LJ; He H; Shi SY; Lei CZ; Zheng L; Peng SJ; Tian YR; Dang RH; Lan XY; Qi XL; Chen H; Huang YZ
Gene; 2018 Nov; 676():243-248. PubMed ID: 30031031
[TBL] [Abstract][Full Text] [Related]
7. Opposite Effects of CRABP1 and CRABP2 Homologs on Proliferation of Breast Cancer Cells and Their Sensitivity to Retinoic Acid.
Enikeev AD; Abramov PM; Elkin DS; Komelkov AV; Beliaeva AA; Silantieva DM; Tchevkina EM
Biochemistry (Mosc); 2023 Dec; 88(12):2107-2124. PubMed ID: 38462454
[TBL] [Abstract][Full Text] [Related]
8. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma.
Liu RZ; Li S; Garcia E; Glubrecht DD; Poon HY; Easaw JC; Godbout R
Glia; 2016 Jun; 64(6):963-76. PubMed ID: 26893190
[TBL] [Abstract][Full Text] [Related]
9. Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas.
Campos B; Warta R; Chaisaingmongkol J; Geiselhart L; Popanda O; Hartmann C; von Deimling A; Unterberg A; Plass C; Schmezer P; Herold-Mende C
Int J Cancer; 2012 Oct; 131(8):1963-8. PubMed ID: 22275178
[TBL] [Abstract][Full Text] [Related]
10. Biological implications of PTEN upregulation and altered sodium/iodide symporter intracellular distribution in resveratrol-suppressed anaplastic thyroid cancer cells.
Xiong L; Nie JH; Lin XM; Wu JB; Chen Z; Xu B; Liu J
J Cancer; 2020; 11(23):6883-6891. PubMed ID: 33123279
[No Abstract] [Full Text] [Related]
11. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
[TBL] [Abstract][Full Text] [Related]
12. Association between mRNA levels of DNMT1, DNMT3A, DNMT3B, MBD2 and LINE-1 methylation status in infants with tetralogy of Fallot.
Sheng W; Qian Y; Wang H; Ma X; Zhang P; Chen L; Ma D; Huang G
Int J Mol Med; 2013 Sep; 32(3):694-702. PubMed ID: 23820632
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
14. RA-Induced Transcriptional Silencing of Checkpoint Kinase-2 through Promoter Methylation by Dnmt3b Is Required for Neuronal Differentiation of P19 Cells.
Sheikh MA; Malik YS; Zhu X
J Mol Biol; 2017 Aug; 429(16):2463-2473. PubMed ID: 28712951
[TBL] [Abstract][Full Text] [Related]
15. CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway.
Liu CL; Hsu YC; Kuo CY; Jhuang JY; Li YS; Cheng SP
Endocrinology; 2022 Oct; 163(12):. PubMed ID: 36240291
[TBL] [Abstract][Full Text] [Related]
16. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
17. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins.
Mirza S; Sharma G; Parshad R; Gupta SD; Pandya P; Ralhan R
J Breast Cancer; 2013 Mar; 16(1):23-31. PubMed ID: 23593078
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.
Casillas MA; Lopatina N; Andrews LG; Tollefsbol TO
Mol Cell Biochem; 2003 Oct; 252(1-2):33-43. PubMed ID: 14577574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
